NIH-funded research NIH-funded research

Using modified endotracheal tubes to reduce pneumonia in critically ill patients

Official title: Randomized Trial of Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia - Prevent 2 Study

Funded at Duke University · NIH-10657255 · Data updated 2026-11-12

This study is looking at a new kind of breathing tube that might help prevent pneumonia in seriously ill patients on ventilators, and it will compare this new tube to a regular one to see if it makes a difference in keeping patients healthier.

More Pneumonia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 19, 2022
Project endMay 31, 2026
Funding year2022
Award (this year)$743,776
NIH project number7R33HL138650-05
Project IDNIH-10657255 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are critically ill patients who require emergency intubation and mechanical ventilation.

Less likely to help

Patients who are not critically ill or do not require mechanical ventilation will not benefit from this research.

What this research studies

This research investigates the effectiveness of a new type of endotracheal tube designed to prevent ventilator-associated pneumonia (VAP) in critically ill patients who require mechanical ventilation. The study will compare a modified tube that allows for continuous aspiration of secretions to a standard tube. Patients will be randomly assigned to receive either the new tube or the conventional one during emergency intubation. The goal is to determine if the modified tube can reduce the risk of pneumonia and improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of pneumonia in patients on mechanical ventilation, leading to shorter hospital stays and improved long-term health outcomes.

How similar studies have gone: Previous pilot studies have shown promising results with similar modified endotracheal tube designs, indicating potential for success in this larger trial.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Treggiari, Miriam — Duke University
  • Study coordinator: Treggiari, Miriam

Related research

Other NIH-funded projects on the same topics.

  • Machine learning to map microbiome changes in ventilator-associated pneumonia

    A machine-learning guided study will analyze 16S microbiome data from mechanically ventilated patients to help identify and diagnose ventillator-associated pneumonia earlier.

    NIH research University of New Haven · West Haven, United States · NIH-11424131

  • Personalizing antibiotic treatment for pneumonia in patients on ventilators

    This study is looking to make the treatment of ventilator-associated pneumonia better by finding ways to personalize how long patients need antibiotics, so they get the right care without extra side effects.

    NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11118911

  • Detecting pneumonia in patients on ventilators

    This study is working on a new, gentle way to help doctors find out if patients on ventilators have pneumonia by collecting tiny particles from their breath, which could lead to quicker and more accurate treatment for those at risk.

    NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-10820510

  • Coordinating ARDS, Pneumonia, and Sepsis research to improve care

    A national coordinating center helps researchers studying ARDS and related infections work together more efficiently to learn what helps patients recover.

    NIH research Vanderbilt University Medical Center · Nashville, United States · NIH-11595454

  • Endothelial inflammation memory after sepsis and pneumonia

    A scientist is studying how blood vessel cells “remember” sepsis and why survivors get worse when they catch pneumonia, with the goal of finding better ways to reduce organ damage.

    NIH research Albany Medical College · Albany, United States · NIH-11572337

  • Bacterial Biofilm Therapy with a Human Antibody to Help Antibiotics Work Better

    A human antibody drug is being studied to disrupt bacterial biofilms and help standard antibiotics clear infections, especially around implants and catheters, in adults.

    NIH research Trellis Bioscience, INC. · Redwood City, UNITED STATES · NIH-11532353

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.